| Primary |
| Pain |
48.1% |
| Back Pain |
5.7% |
| Product Used For Unknown Indication |
5.7% |
| Neuralgia |
5.1% |
| Cardiac Failure Congestive |
4.4% |
| Phantom Pain |
3.2% |
| Depression |
2.5% |
| Drug Use For Unknown Indication |
2.5% |
| Fibromyalgia |
2.5% |
| Hypertension |
2.5% |
| Procedural Pain |
2.5% |
| Anxiety |
1.9% |
| Drug Dependence |
1.9% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Pain Management |
1.9% |
| Postoperative Analgesia |
1.9% |
| Rheumatoid Arthritis |
1.9% |
| Abdominal Discomfort |
1.3% |
| Arthralgia |
1.3% |
| Breakthrough Pain |
1.3% |
|
| Granuloma |
12.5% |
| Somnolence |
9.1% |
| Unresponsive To Stimuli |
9.1% |
| Product Quality Issue |
6.8% |
| Sedation |
6.8% |
| Drug Screen Negative |
5.7% |
| Cardio-respiratory Arrest |
4.5% |
| Completed Suicide |
4.5% |
| Pain |
4.5% |
| Cellulitis |
3.4% |
| Death |
3.4% |
| Lethargy |
3.4% |
| Overdose |
3.4% |
| Pruritus |
3.4% |
| Rash |
3.4% |
| Respiratory Arrest |
3.4% |
| Respiratory Depression |
3.4% |
| Tremor |
3.4% |
| Withdrawal Syndrome |
3.4% |
| Drug Administration Error |
2.3% |
|
| Secondary |
| Product Used For Unknown Indication |
56.1% |
| Drug Abuse |
11.9% |
| Pain |
10.8% |
| Drug Use For Unknown Indication |
4.6% |
| Back Pain |
3.3% |
| Analgesic Therapy |
2.3% |
| Breakthrough Pain |
1.9% |
| Suicide Attempt |
1.5% |
| Pain Management |
1.2% |
| Nausea |
0.9% |
| Abdominal Pain |
0.9% |
| Neuralgia |
0.8% |
| Depression |
0.7% |
| Prostate Cancer |
0.6% |
| Constipation |
0.5% |
| Cardiac Failure Congestive |
0.4% |
| Procedural Pain |
0.4% |
| Abdominal Pain Upper |
0.4% |
| Acute Myeloid Leukaemia |
0.4% |
| Crohn's Disease |
0.4% |
|
| Toxicity To Various Agents |
24.8% |
| Completed Suicide |
10.1% |
| Respiratory Arrest |
9.4% |
| Death |
9.1% |
| Drug Abuse |
8.4% |
| Poisoning |
4.5% |
| Drug Toxicity |
4.2% |
| Pain |
3.8% |
| Intentional Drug Misuse |
2.8% |
| Vomiting |
2.8% |
| Hyperaesthesia |
2.4% |
| Somnolence |
2.4% |
| Overdose |
2.1% |
| Respiratory Depression |
2.1% |
| Unresponsive To Stimuli |
2.1% |
| Urinary Tract Infection |
2.1% |
| Urticaria |
2.1% |
| Stomatitis |
1.7% |
| Colonic Pseudo-obstruction |
1.4% |
| Drug Hypersensitivity |
1.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
37.4% |
| Drug Use For Unknown Indication |
16.1% |
| Pain |
11.8% |
| Hypertension |
3.9% |
| Prophylaxis |
3.8% |
| Nausea |
3.6% |
| Adverse Event |
2.6% |
| Anxiety |
2.3% |
| Multiple Myeloma |
2.2% |
| Depression |
2.1% |
| Constipation |
2.0% |
| Crohn's Disease |
1.7% |
| Back Pain |
1.7% |
| Plasma Cell Myeloma |
1.5% |
| Diffuse Large B-cell Lymphoma |
1.3% |
| Rheumatoid Arthritis |
1.3% |
| Premedication |
1.2% |
| Prostate Cancer |
1.2% |
| Vomiting |
1.0% |
| Gastrooesophageal Reflux Disease |
1.0% |
|
| Vomiting |
18.0% |
| Pain |
8.8% |
| Weight Decreased |
8.6% |
| Death |
7.0% |
| Weight Increased |
5.9% |
| Nausea |
5.3% |
| Pneumonia |
4.8% |
| Pulmonary Embolism |
4.8% |
| Drug Ineffective |
4.6% |
| Thrombocytopenia |
3.9% |
| Pleural Effusion |
3.5% |
| Pyrexia |
3.3% |
| Rash |
3.1% |
| Withdrawal Syndrome |
3.1% |
| Tremor |
2.9% |
| Renal Failure |
2.6% |
| Renal Failure Acute |
2.6% |
| Sepsis |
2.6% |
| Vision Blurred |
2.4% |
| Pain In Extremity |
2.2% |
|
| Interacting |
| Ill-defined Disorder |
28.6% |
| Pain |
28.6% |
| Back Pain |
14.3% |
| Essential Hypertension |
14.3% |
| Post-traumatic Stress Disorder |
14.3% |
|
| Drug Interaction |
33.3% |
| Pulse Abnormal |
33.3% |
| Respiratory Depression |
33.3% |
|
